Amyloid Beta Peptide

Plasma phosphorylated tau at threonine 181 served as “an accessible and scalable marker” of neurodegeneration and cognitive decline specific to Alzheimer’s disease, according to findings published in JAMA Neurology.“Recent evidence suggests that blood-based biomarkers might be useful to detect AD pathology, potentially promoting the widespread use of biomarkers in the diagnostic

Greater amounts of air particulate matter correlated with the development of brain amyloid-beta plaques among older adults with cognitive impairment from over 5,000 U.S. Census tracts, according to a secondary analysis of the IDEAS study.

Primary open-angle glaucoma may be associated with a genetic variation in individuals with African ancestry, a study found.